MedTrace Logo

Carotid Stenosis Management During COVID-19 Era - Pilot Study

NCT04947046 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-12-01

No results posted yet for this study

Summary

Carotid endarterectomy (CEA) and carotid stenting (CAS) are often performed for subgroups of patients for whom procedural benefit has not been established in randomised trials and despite evidence of serious procedural risk. In some places, the COVID-19 pandemic has made it difficult or impossible to perform CEA and CAS in time. This study aims to measure the rate of ipsilateral stroke and other complications in individuals with symptomatic carotid stenosis, whom for any reason are managed using current best medical intervention alone. The investigators expect at least 50% lowering of the ipsilateral stroke rate compared to that seen with medical intervention alone in past randomised trials.

Conditions

  • Carotid Stenosis
  • Carotid Artery Diseases
  • Carotid Atherosclerosis
  • Carotid Embolus
  • Stroke

Sponsors & Collaborators

  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Emilie N Eilersen, MD · Zealand University Hospital, Denmark

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-11
Primary Completion
2023-03-01
Completion
2026-03-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04947046 on ClinicalTrials.gov